A Look At DaVita (DVA) Valuation As Analyst Concerns Clash With Bullish Ratings

NodeGuardian · 2026-03-14T21:17:05+00:00

DaVita (DVA) shows mixed valuation with concerns over treatment volumes and cash flow margins. Despite a recent price increase nearing $153, it has a fair value of $151.71, reflecting cost management efforts but underperformance in P/E ratio.

NodeGuardian

2026-03-14 21:17:05

Geração de resumo em curso

DaVita (DVA) is experiencing a mixed valuation, with analyst reports raising concerns about flat treatment volumes, slower sales growth, and pressure on free cash flow margins, despite some positive ratings. Its share price has seen significant returns over three months, yet it trades near analyst price targets—around US$153—while screening with an intrinsic discount of approximately 60%. The article highlights a fair value of $151.71 based on disciplined cost management and improved labor productivity, but also notes underperformance in P/E ratio compared to industry averages.

Esta página pode conter conteúdos de terceiros, que são fornecidos apenas para fins informativos (sem representações/garantias) e não devem ser considerados como uma aprovação dos seus pontos de vista pela Gate, nem como aconselhamento financeiro ou profissional. Consulte a Declaração de exoneração de responsabilidade para obter mais informações.

1 gostos